All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

PathAI

PathAI is a leading provider of AI-powered research tools and services for pathology.

Boston, United States201–500Artificial Intelligence, Biotech
Series C·$251.0M·May 2021
Opentrons

We make robots for biologists.

New York, United States201–500Biotech, Healthcare
Extension Round·$250.8M·Nov 2025
Vir BiotechnologyIPO

Clinical-stage biotech developing antibody- and T-cell engager-based therapeutics for infectious ...

San Francisco, United States201–500Biotech, Drug Discovery
Growth Equity·$250.0M·Oct 2024
Inhibrx BiosciencesIPO

Clinical-stage biopharmaceutical company developing targeted immunotherapy candidates for life-th...

La Jolla, United States51–200healthtech, Biotech
Private Equity·$250.0M·Aug 2023
Rapport TherapeuticsIPO

Clinical-stage biopharmaceutical company focused on the discovery and development of precision sm...

Boston, United States11–50healthtech, Biotech
Series B·$250.0M·Aug 2023
Novast

Is a generic and specialty pharmaceutical company

Nantong, China501–1000Healthcare, Biotech
Series F·$247.9M·Jan 2021
InventisBioIPO

Clinical-stage biopharmaceutical company developing small-molecule therapies for oncology, autoim...

Shanghai, China11–50Biotech, Life Sciences
Series D·$247.0M·Sep 2020
Seismic Therapeutic

Clinical-stage immunology biotech using machine learning to design biologic therapeutics for auto...

Cambridge, United States51–200Biotech, Drug Discovery
Extension Round·$247.0M·Jul 2025
AIRNA

Clinical-stage biotech pioneering RNA editing therapeutics to repair disease-causing genetic vari...

United States11–50Biotech, Healthcare
Series B·$245.0M·Apr 2025
InterVenn

Life science company using AI-powered glycoproteomics to decode glycosylated proteins for disease...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series C·$244.4M·Aug 2021
Personal Genome DiagnosticsAcquired

Innovative genomic technologies to solve fundamental challenges in oncology

Baltimore, United States51–200Biotech, Cancer Diagnostics
Series C·$244.2M·Feb 2021
Cala Health

Cala Health develops wearable neuromodulation therapies for chronic disease, starting with essent...

Burlingame, United States51–200Biotech, Healthcare
Growth Equity·$244.1M·Dec 2024
Agios PharmaceuticalsIPO

Commercial-stage biopharmaceutical company developing therapies for rare hematologic diseases by ...

Cambridge, United States501–1000Biotech, Healthcare
Series C·$241.0M·Nov 2011
Ray Therapeutics

Developing novel optogenetic gene therapies for patients with blinding diseases.

Berkeley, United States11–50Biotech, Genomics
Series B·$241.0M·Apr 2026
Leyden Labs

Leyden Labs is a clinical-stage biotech developing intranasal antibody sprays that block respirat...

Leiden, Netherlands11–50Biotech, Healthcare
Growth Equity·$240.0M·Oct 2025
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United States51–200Biotech, Therapeutics
Series D·$239.0M·Jul 2020
AntengeneIPO

Commercial-stage biopharmaceutical company developing first-in-class therapeutics for hematologic...

Shanghai, China201–500Biotech, Oncology
Series C·$238.0M·Jul 2020
Nutcracker Therapeutics

Nutcracker Therapeutics is an RNA-focused CRDMO combining microfluidics biochip manufacturing wit...

Emeryville, United States11–50Biotech, Healthcare
Series C·$237.0M·Sep 2021
Deep Genomics

AI-driven biotechnology company using proprietary machine learning platforms to discover and deve...

Toronto, Canada51–200Artificial Intelligence, Biotech
Series C·$236.7M·Jul 2021
MOMA Therapeutics

Clinical-stage precision medicine company targeting highly dynamic molecular machines underlying ...

Cambridge, United States51–200Biotech, Healthcare
Series B·$236.0M·May 2022
Elligo Health Research

Connecting life sciences companies with physicians, patients, and data to accelerate clinical tri...

Austin, United States201–500Biotech, Healthcare
Series E·$236.0M·Sep 2021
Ionis PharmaceuticalsIPO

Pioneer in RNA-targeted medicine developing treatments for serious diseases with few or no existi...

Carlsbad, United States1001–5000healthtech, Biotech
Corporate Round·$235.2M·Apr 2021
Tango TherapeuticsIPO

Clinical-stage biotechnology company discovering novel drug targets and delivering precision canc...

Cambridge, United States51–200healthtech, Biotech
Series C·$235.0M·May 2025
Bright Peak Therapeutics

Biotechnology company advancing multifunctional immunotherapies and next-generation PD-1 inhibito...

Del Mar, United States51–200Biotech, Healthcare
Series C·$232.0M·Jun 2024
Inventiva PharmaIPO

Clinical-stage biopharmaceutical company focused on the development of oral small molecule therap...

Daix, France51–200Biopharmaceutical, MASH Treatment
Growth Equity·$232.0M·May 2025